Lineage Cell Therapeutics, Inc. Annual Amortization of Intangible Assets in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2010 to 2023.
  • Lineage Cell Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $130K, a 10.3% decline from 2022.
  • Lineage Cell Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $145K, a 31% decline from 2021.
  • Lineage Cell Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $210K, a 82.7% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $130K -$15K -10.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $145K -$65K -31% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $210K -$1.01M -82.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $1.22M -$782K -39.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $2M -$194K -8.85% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $2.19M -$157K -6.68% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $2.35M -$1.23M -34.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 $3.58M -$1.68M -31.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $5.26M -$2.1M -28.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 $7.36M +$4.06M +123% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $3.3M +$849K +34.7% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $2.45M +$456K +22.9% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
2011 $1.99M +$1.2M +152% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 $790K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.